Aprea Therapeutics AB   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Stockholm Sweden (2003)

Organization Overview

First Clinical Trial
2009
NCT00900614
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Aprea Therapeutics | Aprea Therapeutics AB